ANI PHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2013 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Ani Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2013 to Q1 2025.
- Ani Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$9.91M, a 49.8% increase year-over-year.
- Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $265M, a 293% increase from 2023.
- Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $67.4M.
- Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$5.13M, a 103% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)